Medicine

Medicine

Posts 1-1 of 1
  • David Rafols
    David Rafols    Group moderator
    The company name is only visible to registered members.
    New antitumoral agents based on a technological platform based on oncolytic adenoviruses
    The deadline for submitting a RFI (Request for information) to innoget’s Technology Offer O_413 “Design of new antitumoral agents based on a technological platform based on oncolytic adenoviruses ” is 2012-05-10.

    A full description can be found in the Tech Offer and associated documents, accessible online at http://tinyurl.com/6h8vwml

    The kind of business relationship our client VCN Biosciences (Spin off, Start up) wants to establish with partners interested in this technology offer is/are: Join venture agreement, Technical cooperation - further development.

    Responding with a RFI is free. Our client will receive your RFI and contact you so that you can discuss the details of this technology and negotiate directly with our client.

    If you are interested in doing a RFI or would like more information, please go to http://tinyurl.com/6h8vwml

    To edit your profile and indicate the Technology Offers categories you are interested in, register online at http://www.innoget.com
    • 13 Jul 2011, 2:13 pm